Nanotrap® High Sensitivity Lyme Antigen Test
A GAME CHANGING SOLUTION FOR LYME DISEASE DIAGNOSIS
There is a critical need for a fast, reliable, and accurate Lyme disease test
Lyme Disease - An Overview
Lyme disease is a bacterial infection carried by ticks. Approximately 30,000 people are diagnosed with Lyme disease in the US every year, a number which has almost doubled in the past decade. Lyme disease is most prominent in the Northeast and Midwest, but cases of Lyme have been confirmed in every state, and it is also becoming prevalent on other continents. Lyme disease is well known for having symptoms that are very similar to those of other diseases. Some of the most common symptoms include a "bulls-eye" rash, fatigue and flu-like symptoms. If left untreated, the disease can seriously affect the heart and central nervous system which can lead to heart inflammation, meningitis, arthritis, memory loss and even paralysis.
How is it Diagnosed?
Lyme disease is diagnosed clinically, based on symptoms and circumstantial factors such as history of a tick bite or prevalence of ticks in the area. Blood tests are often ordered to support a diagnosis, but due to the high number of false positives and negatives that are seen the test results are not considered to be definitive.
The current FDA-recommended testing process involves running an ELISA test which is followed up with a Western blot test if the initial results come back positive or inconclusive. These two tests screen for antibodies, which appear when a person's body is fighting an infection. A person becomes infected with Lyme disease when Lyme antigens enter their body, but it can take weeks or even months for a person to develop enough antibodies to be seen in the tests. This means that many people test negative or inconclusive, even after they've contracted Lyme disease.
The Ceres Solution
The Ceres' Nanotrap® High Sensitivity Lyme Antigen Test uses the Nanotrap® technology to directly measure Lyme antigens in urine using a quantitative ELISA format. The Nanotrap® test is designed to provide high sensitivity and accuracy, delivering confident results at the earliest stages of infection. The Nanotrap® Lyme test is currently undergoing clinical trials at the Inova Infectious Disease Center in Northern Virginia.
For more information, please contact our product development team.
info@ceresnano.com / 800-615-0418
